Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ondrej Holas

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|February 13, 2015
Evaluation of 2,6-dichlorophenolindophenol acetate as a substrate for acetylcholinesterase activity assayMiroslav Pohanka, Ondrej Holas
Journal of Enzyme Inhibition and Medicinal Chemistry|November 11, 2014
Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decadeOndrej Holas, Pavel Ondrejcek, Martin Dolezal
Molecules (Basel, Switzerland)|November 4, 2017
Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme ActivityKristyna Krasulova, Ondrej Holas, Pavel Anzenbacher
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 10, 2019
Nanomaterials for direct and indirect immunomodulation: A review of applicationsJana Kubackova, Jarmila Zbytovska, Ondrej Holas
Expert Opinion on Drug Discovery|September 28, 2012
The progress in the cholinesterase quantification methodsOndrej Holas, Kamil Musilek, Miroslav Pohanka, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 5, 2015
Enantiospecific effects of chiral drugs on cytochrome P450 inhibition in vitroKristyna Krasulova, Michal Siller, Ondrej Holas, et al.
Acta Pharmaceutica (Zagreb, Croatia)|November 3, 2019
Branched PLGA derivatives with tailored drug delivery propertiesEva Snejdrova, Stepan Podzimek, Juraj Martiska, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 3, 2015
Monooxime Bispyridinium Reactivators Bearing Xylene Linker Synthesis and In Vitro Evaluation on Model of Organophosphate-Inhibited AcetylcholinesteraseKamil Musilek, Jan Hambalek, Ondrej Holas, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 13, 2007
Synthesis of a novel series of non-symmetrical bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Ondrej Holas, Kamil Kuca, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2006
Synthesis of asymmetrical bispyridinium compounds bearing cyano-moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Ondrej Holas, Kamil Kuca, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Enzyme Inhibition and Medicinal Chemistry|February 13, 2015
Evaluation of 2,6-dichlorophenolindophenol acetate as a substrate for acetylcholinesterase activity assayMiroslav Pohanka, Ondrej Holas
Journal of Enzyme Inhibition and Medicinal Chemistry|November 11, 2014
Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decadeOndrej Holas, Pavel Ondrejcek, Martin Dolezal
Molecules (Basel, Switzerland)|November 4, 2017
Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme ActivityKristyna Krasulova, Ondrej Holas, Pavel Anzenbacher
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 10, 2019
Nanomaterials for direct and indirect immunomodulation: A review of applicationsJana Kubackova, Jarmila Zbytovska, Ondrej Holas
Expert Opinion on Drug Discovery|September 28, 2012
The progress in the cholinesterase quantification methodsOndrej Holas, Kamil Musilek, Miroslav Pohanka, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 5, 2015
Enantiospecific effects of chiral drugs on cytochrome P450 inhibition in vitroKristyna Krasulova, Michal Siller, Ondrej Holas, et al.
Acta Pharmaceutica (Zagreb, Croatia)|November 3, 2019
Branched PLGA derivatives with tailored drug delivery propertiesEva Snejdrova, Stepan Podzimek, Juraj Martiska, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 3, 2015
Monooxime Bispyridinium Reactivators Bearing Xylene Linker Synthesis and In Vitro Evaluation on Model of Organophosphate-Inhibited AcetylcholinesteraseKamil Musilek, Jan Hambalek, Ondrej Holas, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 13, 2007
Synthesis of a novel series of non-symmetrical bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Ondrej Holas, Kamil Kuca, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2006
Synthesis of asymmetrical bispyridinium compounds bearing cyano-moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesteraseKamil Musilek, Ondrej Holas, Kamil Kuca, et al.
Pageof 4